Call for Patient and Caregiver Engagement


LCC is looking for lung cancer patients and their caregivers, in Canada or the US, who have received either:

  • Cyramza (Ramucirumab) or
  • Keytruda (Pembrolizumab) or
  • Tagrisso (Osimertinib)

who are willing to share their experience (anonymously) with the drug.

Patient and caregiver experience is a key element in drug approvals and recommendations. We need your help!

Contact us at info@lungcancercanada.ca